Holen Sie sich die Stockscreener-App
2.80
0.36%
0.010
Handel nachbörslich:
2.81
0.01
+0.36%
Schlusskurs vom Vortag:
$2.79
Offen:
$2.78
24-Stunden-Volumen:
1.46M
Relative Volume:
0.48
Marktkapitalisierung:
$950.41M
Einnahmen:
$775.09M
Nettoeinkommen (Verlust:
$-58.68M
KGV:
-21.12
EPS:
-0.1326
Netto-Cashflow:
$64.06M
1W Leistung:
+1.82%
1M Leistung:
+3.70%
6M Leistung:
-42.51%
1J Leistung:
-34.58%
1-Tages-Spanne:
$2.73
$2.8288
1-Wochen-Bereich:
$2.73
$2.92
52-Wochen-Spanne:
$2.61
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Firmenname
Goodrx Holdings Inc
Sektor
Branche
Telefon
(855) 268-2822
Adresse
2701 OLYMPIC BOULEVARD, SANTA MONICA
Vergleichen Sie GDRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.80 | 947.02M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-10 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-07-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Eingeleitet | Citigroup | Buy |
| 2022-11-04 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-12 | Eingeleitet | DA Davidson | Neutral |
| 2022-06-10 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-06 | Fortgesetzt | BofA Securities | Buy |
| 2022-06-01 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Bestätigt | Barclays | Overweight |
| 2022-03-01 | Bestätigt | BofA Securities | Neutral |
| 2022-03-01 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-03-01 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Bestätigt | Evercore ISI | Outperform |
| 2022-03-01 | Bestätigt | Goldman | Buy |
| 2022-03-01 | Bestätigt | JP Morgan | Underweight |
| 2022-03-01 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-03-01 | Bestätigt | SVB Leerink | Outperform |
| 2022-01-07 | Eingeleitet | Goldman | Buy |
| 2021-12-21 | Eingeleitet | Stephens | Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-08-31 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-01-25 | Eingeleitet | Guggenheim | Buy |
| 2020-11-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Eingeleitet | Barclays | Equal Weight |
| 2020-10-19 | Eingeleitet | BofA Securities | Neutral |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-10-19 | Eingeleitet | Credit Suisse | Outperform |
| 2020-10-19 | Eingeleitet | Deutsche Bank | Hold |
| 2020-10-19 | Eingeleitet | Goldman | Neutral |
| 2020-10-19 | Eingeleitet | JP Morgan | Neutral |
| 2020-10-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-10-19 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2020-10-19 | Eingeleitet | UBS | Buy |
Alle ansehen
Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten
Citigroup Maintains Buy Rating on GoodRx (GDRX) but Lowers Price Target | GDRX Stock News - GuruFocus
Can GoodRx Holdings Inc. stock deliver strong Q4 earningsJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
What Wall Street predicts for GoodRx Holdings Inc. stock priceJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - ulpravda.ru
Aug Wrap: Is GoodRx Holdings Inc. stock positioned for digital transformationIPO Watch & Daily Profit Maximizing Trade Tips - ulpravda.ru
Is GoodRx Holdings Inc. stock positioned for digital transformationIPO Watch & Daily Profit Maximizing Trade Tips - ulpravda.ru
How supply chain issues affect GoodRx Holdings Inc. stockEarnings Beat & AI Powered Market Entry Ideas - ulpravda.ru
Can GoodRx Holdings Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Target Return Focused Picks - ulpravda.ru
Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Summary & Accurate Technical Buy Alerts - ulpravda.ru
Is GoodRx Holdings Inc. stock a safe buy before earningsForecast Cut & High Conviction Buy Zone Alerts - ulpravda.ru
Scan a code at Giant Eagle to unlock cheaper Ozempic and Wegovy - Stock Titan
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring A 71.61% Upside Potential - DirectorsTalk Interviews
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Benzinga
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds - Investing.com UK
GoodRx Holdings Inc. (GDRX) PT Lowered to $2.60 at BofA Securities, Underperofrm, 'We Remain Cautious' - StreetInsider
New Wegovy weight-loss pill now $149 a month through GoodRx - Stock Titan
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds By Investing.com - Investing.com Nigeria
Preferred dividends of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
GoodRx Holdings And 2 Other Compelling Penny Stocks To Consider - Yahoo Finance
Morgan Stanley favors GoodRx (GDRX) and healthcare tech over managed care for 2026 citing strong market-beating potential - MSN
Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential - Finviz
Aug Mood: Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Report & Verified Chart Pattern Trade Signals - moha.gov.vn
Yakima Topic GOODRX HOLDINGS, INC. | News, Weather, Sports, Breaking News - KIMA
When Should You Buy GoodRx Holdings, Inc. (NASDAQ:GDRX)? - Yahoo Finance
GoodRx: The Tide Is Shifting Out Of This Company's Favor (Downgrade) (GDRX) - Seeking Alpha
Check out GoodRx Holdings's stock price (8GH-FF) in real time - CNBC
Can GoodRx Holdings Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - Улправда
GoodRx Holdings (GDRX): Morgan Stanley Lowers Price Target to $4 - GuruFocus
Will GoodRx Holdings Inc. stock benefit from commodity pricesJuly 2025 Short Interest & Smart Allocation Stock Reports - Улправда
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - TradingView — Track All Markets
GoodRx approves retention bonuses for CEO and CFO - MSN
GoodRx Approves Retention Bonuses for CEO and CFO - The Globe and Mail
[8-K] GoodRx Holdings, Inc. Reports Material Event | GDRX SEC FilingForm 8-K - Stock Titan
Why GoodRx (GDRX) Stock Is Trading Lower Today - Finviz
Barclays Initiates Coverage of GoodRx Holdings (GDRX) with Underweight Recommendation - Nasdaq
Barclays Initiates Coverage on GoodRx Holdings (GDRX) with Under - GuruFocus
What Does Wall Street Think About GoodRx Holdings (GDRX)? - Insider Monkey
What does Wall Street think about GoodRx Holdings (GDRX)? - MSN
Officer Nabiey Acquires 7,983 Of GoodRx Holdings Inc [GDRX] - TradingView — Track All Markets
Is GoodRx Holdings Inc a good long term investmentRelative Strength Index (RSI) & Free Tremendous Growth Opportunities - earlytimes.in
9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years - Insider Monkey
Will GoodRx Holdings Inc. stock outperform value stocksJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Why The Narrative Around GoodRx Is Shifting Amid New Partnerships And Industry Uncertainty - Yahoo Finance
Declining Stock and Decent Financials: Is The Market Wrong About GoodRx Holdings, Inc. (NASDAQ:GDRX)? - 富途牛牛
Will GoodRx Holdings Inc. stock deliver long term returnsPortfolio Profit Report & Community Supported Trade Ideas - Newser
Finanzdaten der Goodrx Holdings Inc-Aktie (GDRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.07%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):